Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002683053 | SCV003549500 | uncertain significance | Inborn genetic diseases | 2022-08-02 | criteria provided, single submitter | clinical testing | The c.138G>C (p.Q46H) alteration is located in exon 2 (coding exon 1) of the TRIM32 gene. This alteration results from a G to C substitution at nucleotide position 138, causing the glutamine (Q) at amino acid position 46 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005050770 | SCV005682458 | uncertain significance | Sarcotubular myopathy; Bardet-Biedl syndrome 11 | 2024-02-28 | criteria provided, single submitter | clinical testing |